IMMUNIC, INC. — Director's Dealing 2014

Oct 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-10-10

Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-10	Common Stock	P	680	$14.81	Acquired	183762	Direct
2014-10-10	Common Stock	P	680	$14.90	Acquired	184442	Direct

Footnotes

F1: Includes 123,204 shares that were reported as indirectly held by the Reporting Person and his wife in the Form 4 filed April 23, 2014. These shares should have been reported as directly held by the Reporting Person.